Proteus by Seqens
Entity

  • Proteus by Seqens

    Created in 1997

  • Social networks

    3,238

  • Activities

    deeptech

  • Technologies

    Synthetic Biology

  • Entity types

    SMB

  • Location

    70 All. Graham Bell, 30000 Nîmes, France

    Nîmes

    France

  • Employees

    Scale: 11-50

    Estimated: 24

  • Engaged catalyst

    1
    0 0

  • Added in Motherbase

    1 year, 4 months ago
Description
  • Value proposition

    Biocatalysis from Lab to Industrial Scale

    Protéus is a pioneer in protein engineering technologies, with now 20 years expertise in developing tailored enzymes and scaling-up biocatalytic processes.
    Proteus offers:
    - An exclusive and diversified microorganism collection (including micro-algae and thousands of bacteria and archaebacteria extremophiles strains)
    - 1,000 sequenced strains, combined with data mining tools, offering a unique pool of millions enzymes
    - Patented directed evolution technologies (EvoSightTM & L-ShufflingTM) to optimize enzymes performances
    - A multidisciplinary skilled team dedicated to custom bioprocess development for client’s applications
    - Seqens CDMO capabilities enabling large scale biocatalytic production of chemicals & pharmaceuticals
    - A range of proprietary Bioproducts


    Biotechnology, Industrial Biology, Bioenergy, Chemistry, Environment, Biocatalysis, Microbiology, enzymes, and lifesciences

  • Original language

    Biocatalysis from Lab to Industrial Scale

    Protéus is a pioneer in protein engineering technologies, with now 20 years expertise in developing tailored enzymes and scaling-up biocatalytic processes.
    Proteus offers:
    - An exclusive and diversified microorganism collection (including micro-algae and thousands of bacteria and archaebacteria extremophiles strains)
    - 1,000 sequenced strains, combined with data mining tools, offering a unique pool of millions enzymes
    - Patented directed evolution technologies (EvoSightTM & L-ShufflingTM) to optimize enzymes performances
    - A multidisciplinary skilled team dedicated to custom bioprocess development for client’s applications
    - Seqens CDMO capabilities enabling large scale biocatalytic production of chemicals & pharmaceuticals
    - A range of proprietary Bioproducts

Catalyst interactions
Catalyst TypeTweets Articles
Merck Group
Merck Group
Pharmaceutical, Biotechnology, Pharmaceutical Manufacturing
Merck Group
Pharmaceutical, Biotechnology, Pharmaceutical Manufacturing 		Other

30 Nov 2023


Social network dynamics
Similar entities
BETA
Last news
Show all articles